An independent practice validation of the Prostate Imaging Reporting and Data System version 2 scoring system and the introduction of PDP (prostate-specific antigen density × PI-RADSv2) score to assist with further risk assessment

OBJECTIVES: To provide concise information to clinicians on how to better interpret multiparametric magnetic resonance imaging for prostate cancer risk stratification. MATERIALS AND METHODS: We analyzed 2 separate cohorts. For patients receiving a Prostate Imaging Reporting and Data System version 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Parth U., Bock, David, Hettinger, Christian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Special Topic: Advances in Prostate Cancer Therapy: Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875202/
https://www.ncbi.nlm.nih.gov/pubmed/36714236
http://dx.doi.org/10.1097/CU9.0000000000000140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875202/
https://www.ncbi.nlm.nih.gov/pubmed/36714236
http://dx.doi.org/10.1097/CU9.0000000000000140

Ejemplares similares